Epinephrine is under development for the treatment of allergic reactions, including anaphylaxis and allergic rhinitis. It is administered through nasal route in the form of powder. The drug candidate ...
Discover the top 19 most notable drugs approved by the FDA in 2024, including Dupixent for COPD and FluMist for self-administration. See the full list here.
Astellas Pharma and Endo subsidiary Endo USA issued voluntary recalls for products they manufacture over concerns of empty tablets and unapproved ingredients, respectively. | Astellas Pharma and Endo ...
Epinephrine is under clinical development by Aquestive Therapeutics and currently in Phase I for Anaphylaxis. According to GlobalData, Phase I drugs for Anaphylaxis have an 89% phase transition ...